Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus

BACKGROUND: Fibroblast growth factor 21 (FGF21) has demonstrated beneficial effects on lipid and carbohydrate metabolism. In cross‐sectional studies, an association of raised circulating FGF21 levels with coronary heart disease (CHD) was found in some but not all studies. Here we investigated prospe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Lee, Chi Ho, Woo, Yu Cho, Chow, Wing Sun, Cheung, Chloe Yu Yan, Fong, Carol Ho Yi, Yuen, Michele Mae Ann, Xu, Aimin, Tse, Hung Fat, Lam, Karen Siu Ling
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669163/
https://ncbi.nlm.nih.gov/pubmed/28588089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.005344
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados